Home/Filings/4/0000950170-25-071658
4//SEC Filing

Tate Leah 4

Accession 0000950170-25-071658

CIK 0000913142other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 5:41 PM ET

Size

27.5 KB

Accession

0000950170-25-071658

Insider Transaction Report

Form 4
Period: 2025-05-13
Tate Leah
SVP - HR
Transactions
  • Exercise/Conversion

    Common Stock

    2025-05-13$85.77/sh+1,667$142,97931,837 total
  • Disposition to Issuer

    Common Stock

    2025-05-13$113.85/sh1,436$163,48930,401 total
  • Sale

    Common Stock

    2025-05-14$113.64/sh231$26,25130,170 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2025-05-131,6671,666 total
    Exercise: $85.77Exp: 2033-03-07Common Stock (1,667 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    3,360
  • Common Stock

    (indirect: By 401(k))
    1,163.666
Footnotes (5)
  • [F1]The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.
  • [F2]This represents the difference between the number of SARs exercised (1,667) and the number of shares issued as a result of the exercise (231). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($113.85) and the exercise price ($85.77). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
  • [F3]Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
  • [F4]The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.
  • [F5]The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.

Issuer

BELDEN INC.

CIK 0000913142

Entity typeother

Related Parties

1
  • filerCIK 0001916589

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 5:41 PM ET
Size
27.5 KB